Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 978-981

  Shiomi, Susumu ^a   Nishiguchi, Shuhei ^a   Kubo, Shoji ^a   Tamori, Akihiro ^a   Habu, Daiki ^a   Takeda, Tadashi ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MENATETRENONE; DRUG DERIVATIVE; FARNOQUINONE; HEMOSTATIC AGENT;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIVER CIRRHOSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIRUS HEPATITIS; HEPATITIS B; HEPATITIS C; LUMBAR VERTEBRA; MIDDLE AGED; RADIODENSITOMETRY; RADIOGRAPHY; TIME;

ADULT; AGED; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HEMOSTATICS; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; TIME FACTORS; VITAMIN K 2;

EID: 0036005744     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)03974-6     Document Type: Article

References (20)

1. Bone disease in alcohol abuse
2. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy
3. Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy X-ray absorptiometry
4. Circulation levels of vitamin K1 and K2 decreased in elderly women with hip fracture
5. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
6. Plasma vitamin K1 level is decreased in primary biliary cirrhosis
7. Transection of esophagus for bleeding esophageal varices
8. Bone loss after orthotopic liver transplantation
9. Bone loss after liver transplantation
10. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
11. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double blind, placebo control trial
12. Effect of interferon α on calcium and bone metabolism in patients with chronic hepatitis
13. Interferons-α and -γ inhibit interleukin-1 β-stimulated osteoclast-like cell formation in long-term human marrow cultures
14. Calcitriol for bone disease in patients with cirrhosis of the liver
15. Calcium-dependent α-helical structure in osteocalcin
16. Increased bone formation in osteocalcin-deficient mice
17. Maternal and fetal sequelae of anticoagulation during pregnancy
18. Menatetrenone inhibits bone resorption partly though inhibition of PGE2 synthesis in vitro
19. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures
20. Serum undecarboxylated osteocalcin is a maker of the risk of hip fracture in eldery women